The Permeability and Cytotoxicity of Insulin-Mimetic Vanadium Compounds
Tóm tắt
Purpose. The aim of this study was to investigate the mechanism of permeation and cytotoxicity of vanadium compounds, [VO(acac)2], [VO(ma)2], and vanadate.
Methods. Absorptive transport were carried out in Caco-2 monolayers grown on transwell inserts. Vanadium was quantified using inductively coupled plasma atomic emission spectrometry (ICP-AES). The change of Caco-2 cells in the microvilli morphology and F-actin structure was visualized by transmission electron microscopy and confocal laser scanning microscopy.
Results. The three vanadium compounds were taken up by Caco-2 cells via simple passive diffusion. [VO(acac)2] were mainly transcellularly transported and exhibited the highest apparent permeabilty coefficients (8.2 × 10-6 cm-1). The cell accumulation of [VO(acac)2] was found to be greater than that of [VO(ma)2], and vanadate caused much less accumulation than the other two compounds. Vanadium compounds induced intracellular reactive oxygen species, reduced the transepithelial electric resistance, caused morphological change in microvilli, and led to different perturbation of F-actin structure.
Conclusions. The three compounds exhibited different permeability due to different diffusion process and cellular uptake. The toxicity of vanadium complexes on Caco-2 monolayer involved F-actin-related change of tight junction and impairment of microvilli. The toxicity was also related to elevated intracellular reactive oxygen species (ROS) and their cellular accumulation.
Tài liệu tham khảo
N. Cohen, M. Halberstam, P. Shlimovich, C. J. Chang, H. Shamoon, and L. Rossetti. Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin-dependent diabetes mellitus. J. Clin. Invest. 95:2501-2509 (1995).
A. B. Goldfine, D. C. Simonson, F. Folli, M. E. Patti, and C. R. Kahn. In vivo and in vitro studies of vanadate in human and rodent diabetes mellitus. Mol. Cell. Biochem. 153:217-231 (1995).
K. H. Thompson, J. H. McNeill, and C. Orvig. Vanadium compounds as insulin mimics. Chem. Rev. 99:2561-2572 (1999).
C. Orvig, K. H. Thompson, M. Battell, and J. H. McNeill. Vanadium compounds as insulin mimics. Met. Ions Biol. Syst. 31:575-594 (1995).
J. Li, G. Elberg, D. C. Crans, and Y. Shechter. Evidence for the distinct vanadyl(+4)-dependent activating system for manifesting insulin-like effects. Biochemistry 35:8314-8318 (1996).
X. G. Yang, K. Wang, J. F. Lu, and D. C. Crans. Membrane transport of vanadium compounds and the interaction with the erythrocyte membrane. Coord. Chem. Rev. 237:103-111 (2003).
C. Orvig, K. H. Thompson, B. D. Liboiron, J. H. McNeill, and V. G. Yuen. Biolocalization and in vivo coordination chemistry of vanadium pharmaceuticals. J. Inorg. Biochem. 96:14(2003).
I. J. Hidalgo, T. J. Raub, and R. T. Borchardt. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 96:736-749 (1989).
S. Yamashita, T. Furubayashi, M. Kataoka, T. Sakane, H. Sezaki, and H. Tokuda. Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells. Eur. J. Pharm. Sci. 10:195-204 (2000).
K. H. Thompson, Y. Tsukada, Z. Xu, M. Battell, J. H. McNeill, and C. Orvig. Influence of chelation and oxidation state on vanadium bioavailability, and their effects on tissue concentrations of zinc, copper, and iron. Biol. Trace Elem. Res. 86:31-44 (2002).
J. A. Gordon. Use of vanadate as protein-phosphotyrosine phosphatase inhibitor. Methods Enzymol. 201:477-482 (1991).
V. G. Yuen, P. Caravan, L. Gelmini, N. Glover, J. H. McNeill, I. A. Setyawati, Y. Zhou, and C. Orvig. Glucose-lowering properties of vanadium compounds: comparison of coordination complexes with maltol or kojic acid as ligands. J. Inorg. Biochem. 68:109-116 (1997).
K. H. Thompsonand and C. Orvig. Design of vanadium compounds as insulin enhancing agents. J. Chem. Soc. Dalton Trans. 2885-2892 (2000).
B. A. Reul, S. S. Amin, J. P. Buchet, L. N. Ongemba, D. C. Crans, and S. M. Brichard. Effects of vanadium complexes with organic ligands on glucose metabolism: a comparison study in diabetic rats. Br. J. Pharmacol. 126:467-477 (1999).
D. C. Crans. Chemistry and insulin-like properties of vanadium(IV) and vanadium(V) compounds. J. Inorg. Biochem. 80:123-131 (2000).
T. Mosmann. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65:55-63 (1983).
S. Fraga, B. Sampaio-Maia, M. P. Serrao, and P. Soares-da-Silva. Regulation of apical transporter of L-DOPA in human intestinal Caco-2 cells. Acta Physiol. Scand. 175:103-111 (2002).
W. A. Alrefai, S. Tyagi, F. Mansour, S. Saksena, I. Syed, K. Ramaswamy, and P. K. Dudeja. Sulfate and chloride transport in Caco-2 cells: differential regulation by thyroxine and the possible role of DRA gene. Am. J. Physiol. Gastrointest. Liver Physiol. 280:G603-G613 (2001).
P. Caravan, L. Gelmini, N. Glover, F. G. Herring, H. Li, J. H. McNeill, S. J. Rettig, I. A. Setyawati, E. Shuter, Y. Sun, A. S. Tracey, V. G. Yuen, and C. Orvig. J. Am. Chem. Soc. 117:12759-12770 (1995).
X. G. Yangand and X. D. Yang. ADME/Tox approach in inorganic medicinal chemistry. Prog. Chem. 14:273-278 (2002).
S. J. Stohsand and D. Bagchi. Oxidative mechanisms in the toxicity of metal ions. Free Radic. Biol. Med. 18:321-336 (1995).
S. Melov, P. Coskun, M. Patel, R. Tuinstra, B. Cottrell, A. S. Jun, T. H. Zastawny, M. Dizdaroglu, S. I. Goodman, T. T. Huang, H. Miziorko, C. J. Epstein, and D. C. Wallace. Mitochondrial disease in superoxide dismutase 2 mutant mice. Proc. Natl. Acad. Sci. USA 96:846-851 (1999).
M. Arai, H. Imai, T. Koumura, M. Yoshida, K. Emoto, M. Umeda, N. Chiba, and Y. Nakagawa. Mitochondrial phospholipid hydroperoxide glutathione peroxidase plays a major role in preventing oxidative injury to cells. J. Biol. Chem. 274:4924-4933 (1999).
P. Arturssonand and C. Magnusson. Epithelial transport of drugs in cell culture. II: effect of extracellular calcium concentration on the paracellular transport of drugs of different lipophilicities across monolayers of intestinal epithelial (Caco-2) cells. J. Pharm. Sci. 79:595-600 (1990).
S. A. Peralta, J. M. Mullin, K. A. Knudsen, and C. W. Marano. Tissue remodeling during tumor necrosis factor-induced apoptosis in LLC-PK1 renal epithelial cells. Am. J. Phys. 270:F869-F879 (1996).
X. G. Yang, L. Yuan, K. Wang, and X. D. Yang. Comparision of intestinal absorption of two insulin-mimic vanadyl complexes using Caco-2 monolayers as model system. Chinese Science Bulletin 48:876-881 (2003).